| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |